e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months: follow-up of a longitudinal clinical study
Magnus Ekström, Hans Bornefalk, C. Magnus Sköld, Christer Janson, Anders Blomberg, Jacob Sandberg, Anna Bornefalk-Hermansson, David C. Currow, Miriam J. Johnson, Josefin Sundh
Source:
Eur Respir J, 57 (3) 2002823; 10.1183/13993003.02823-2020
Journal Issue:
March
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Magnus Ekström, Hans Bornefalk, C. Magnus Sköld, Christer Janson, Anders Blomberg, Jacob Sandberg, Anna Bornefalk-Hermansson, David C. Currow, Miriam J. Johnson, Josefin Sundh. Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months: follow-up of a longitudinal clinical study. Eur Respir J, 57 (3) 2002823; 10.1183/13993003.02823-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Long-term predictors of lung function decrease in asthmatics: a 9 year follow-up study
Source: Eur Respir J 2006; 28: Suppl. 50, 145s
Year: 2006
Pulmonary sequelae in patients with COVID-19: results after 3 months of follow-up
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021
Does daily SMS increase adherence to asthma treatment? A three months follow-up study
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009
Decline in function in preclinical COPD patients: a 6 years follow up study.
Source: International Congress 2017 – Assessing the functional status of patients with COPD
Year: 2017
Trajectory of patient-reported outcomes (PROMs) up to 6 months after hospitalization for SARS-CoV-2
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021
Lung function abnormalities in asthmatic children (a 3-5 year follow-up study)
Source: Eur Respir J 2001; 18: Suppl. 33, 120s
Year: 2001
Four years follow-up of exacerbations in a cohort of COPD patients: 1 year interim results (EXACO study)
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Outcomes of 6-9-12 months’ bedaquiline-containing regimens in MDR/XDR TB after 24 months follow up
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Pharmacoeconomic evaluation of COPD: A 1 year follow-up study
Source: Annual Congress 2010 - Influence of delivery of care on outcome parameters: therapy is more than medication prescription
Year: 2010
Clinical outcomes and quality of life of COVID-19 survivors: a follow-up of 3 months post hospital discharge
Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era
Year: 2021
Severe COVID-19 pneumonia: clinical, functional, and imaging outcomes at 4 months
Source: Virtual Congress 2021 – Chronic COVID - 19
Year: 2021
COVID-19: Is pulmonary damage present after 10 weeks follow-up?
Source: Virtual Congress 2021 – Chronic COVID - 19
Year: 2021
COPD eDiary compliance: Comparison of age, symptom score, duration in clinical trial and country of origin
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010
Which method is effective in patient with asthma to guide the treatment? (2 year follow-up study)
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009
No severe exacerbation with 6 months of high-intensity interval training in the REPLACE study. Preliminary data.
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
Two versus three months rehabilitation with the same number of sessions in patients with moderate to severe COPD: analysis of the results
Source: Eur Respir J 2004; 24: Suppl. 48, 244s
Year: 2004
Clinical indicators of treatment response to Mepolizumab at 12 weeks
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Evaluation of asthma control and quality of life after 6 months of treatment with FDC Budesonide/Formoterol-BOREAS study.
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Pulmonary function and tomographic features of COVID-19 survivors 2 months after hospital discharge: a cohort study
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021
Cardiopulmonary exercise testing to assess persistent symptoms at 6 months in people with COVID-19 who survived hospitalisation – A pilot study.
Source: Virtual Congress 2021 – Assessing the impact of COVID-19 on lung function
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept